-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Gender-Affirming Hormone Therapy in the Transgender Patient: Influence on Thrombotic Risk

Program: Education Program
Session: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
Monday, December 9, 2024, 2:45 PM-4:00 PM

Joseph J. Shatzel, MD

Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR

Disclosures: No relevant conflicts of interest to declare.

See more of: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
See more of: Education Program
<< Previous Presentation | Next Presentation >>